These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12090361)

  • 21. Treatment. Study findings show HAART drugs benefit pregnant women.
    AIDS Policy Law; 2007 Oct; 22(19):2. PubMed ID: 18210649
    [No Abstract]   [Full Text] [Related]  

  • 22. Perinatal HIV transmission. New rapid test could reduce rates.
    Barringer S; Williams A
    Adv Nurse Pract; 2000 Nov; 8(11):69-70, 73-4. PubMed ID: 12397919
    [No Abstract]   [Full Text] [Related]  

  • 23. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Kaplan JE; Masur H; Holmes KK; Wilfert CM; Sperling R; Baker SA; Trapnell CB; Freedberg KA; Cotton D; Powderly WG
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S12-31. PubMed ID: 8547500
    [No Abstract]   [Full Text] [Related]  

  • 24. Cotrimoxazole prophylaxis in HIV-infected pregnant women: only a first step.
    Heather Watts D; Mofenson LM
    J Infect Dis; 2006 Dec; 194(11):1478-80. PubMed ID: 17083031
    [No Abstract]   [Full Text] [Related]  

  • 25. 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV: Part II. Prevention of the first episode of disease. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. U.S. Public Health Service/Infectious Diseases Society of America.
    Am Fam Physician; 2000 Jan; 61(2):441-2, 445-9, 453-4 passim. PubMed ID: 10670509
    [No Abstract]   [Full Text] [Related]  

  • 26. U.S. Public Health Service/Infectious Diseases Society of America (USPHS/IDSA) guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.
    Pediatr AIDS HIV Infect; 1995 Dec; 6(6):372-96. PubMed ID: 11361464
    [No Abstract]   [Full Text] [Related]  

  • 27. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV: Part III. Prevention of disease recurrence. U.S. Department of Health and Human Services, Public Health Service. Centers for Disease Control and Prevention.
    Am Fam Physician; 1997 Oct; 56(5):1387-92. PubMed ID: 9337761
    [No Abstract]   [Full Text] [Related]  

  • 28. [German-Austrian guidelines for HIV therapy during pregnancy (May, 2001, update].
    Buchholz B; ;
    Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S19-31. PubMed ID: 12736864
    [No Abstract]   [Full Text] [Related]  

  • 29. The value of highly active antiretroviral therapy in the prevention of mother-to-child transmission of HIV.
    Chama C; Gashau W; Oguche S
    J Obstet Gynaecol; 2007 Feb; 27(2):134-7. PubMed ID: 17454457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Human immunodeficiency virus in newborn of infected mothers: pregnancy, breast feeding and prevention].
    Mor Z; Chemtob D; Pessach N; Nitzan-Kaluski D
    Harefuah; 2006 Sep; 145(9):682-6, 701. PubMed ID: 17078432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal HIV testing and antiretroviral prophylaxis at an urban hospital--Atlanta, Georgia, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jan; 52(51-52):1245-8. PubMed ID: 14704648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1997 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV: Part II. Prevention of first episode of disease.
    Am Fam Physician; 1997 Sep; 56(4):1131-46. PubMed ID: 9310065
    [No Abstract]   [Full Text] [Related]  

  • 33. Toxoplasmosis diagnosis in pregnant women infected with human immunodeficiency virus I.
    Hassl A; Tuma W
    Pediatr Infect Dis J; 1995 Nov; 14(11):1016-7. PubMed ID: 8584346
    [No Abstract]   [Full Text] [Related]  

  • 34. USPHS and IDSA collaborate on guidelines to prevent opportunistic infections in HIV-infected persons.
    Kaplan JE; Holmes KK
    Emerg Infect Dis; 1995; 1(3):102-3. PubMed ID: 8903176
    [No Abstract]   [Full Text] [Related]  

  • 35. Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States.
    Jamieson DJ; Clark J; Kourtis AP; Taylor AW; Lampe MA; Fowler MG; Mofenson LM
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S26-32. PubMed ID: 17825647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Care and management of the infant of the HIV-1-infected mother.
    Paintsil E; Andiman WA
    Semin Perinatol; 2007 Apr; 31(2):112-23. PubMed ID: 17462496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    MMWR Recomm Rep; 1997 Jun; 46(RR-12):1-46. PubMed ID: 9214702
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV.
    Thorne C; Newell ML
    Semin Fetal Neonatal Med; 2007 Jun; 12(3):174-81. PubMed ID: 17321814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
    Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
    Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.